Timolol
- 1 April 1977
- journal article
- research article
- Published by American Medical Association (AMA) in American Journal of Ophthalmology
- Vol. 95 (4), 601-604
- https://doi.org/10.1001/archopht.1977.04450040067008
Abstract
• Timolol maleate, a β-adrenergic blocking agent, was studied in 30 patients With glaucoma. Significant intraocular pressure lowering was achieved with 0.5% and 1.5% solution of the drug. At seven hours following treatment, the IOP was lowered 50% from the pretreatment pressure with both strengths of timolol. There Were no subjective or objective ocular or systemic side effects detected. Visual acuity and pupil response were unchanged from pretreatment levels throughout the study. β-Adrenergic blocking agents and specifically timolol may be an important breakthrough for the medical management of glaucoma. (Arch Ophthalmol 95:601-604, 1977)This publication has 7 references indexed in Scilit:
- INTRAOCULAR-PRESSURE DECREASE IN NORMAL VOLUNTEERS FOLLOWING TIMOLOL OPHTHALMIC SOLUTION1976
- Effect of pindolol on intraocular pressure.British Journal of Ophthalmology, 1975
- Cutaneous and Ocular Reactions to PractololBMJ, 1974
- Topical propranolol and ocular tension in the human.British Journal of Ophthalmology, 1972
- Recent Experimental, Clinical, and Therapeutic Research on the Problems of Intraocular Pressure and GlaucomaAmerican Journal of Ophthalmology, 1972
- Effect of dl- and d-propranolol on ocular tension in rabbits and patientsExperimental Eye Research, 1970
- Propranolol as ocular hypotensive agent.British Journal of Ophthalmology, 1967